Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

8.1%

3 terminated/withdrawn out of 37 trials

Success Rate

91.7%

+5.2% vs industry average

Late-Stage Pipeline

51%

19 trials in Phase 3/4

Results Transparency

58%

19 of 33 completed trials have results

Key Signals

19 with results

Enrollment Performance

Analytics

Phase 4

13(36.1%)

Phase 2

11(30.6%)

Phase 3

6(16.7%)

Phase 1

5(13.9%)

N/A

1(2.8%)

36Total

Phase 4(13)

Phase 2(11)

Phase 3(6)

Phase 1(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (37)

Showing 20 of 37 trials

NCT00161304Phase 2Completed

Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency

Role: collaborator

NCT00124514Phase 2Completed

Triptorelin for Ovary Protection in Childhood Onset Lupus

Role: collaborator

NCT03440359Phase 2Completed

Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole

Role: collaborator

NCT02749825Phase 4Terminated

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Role: collaborator

NCT00224081Phase 4Completed

DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)

Role: lead

NCT02193139Phase 2Completed

Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis

Role: lead

NCT01144949Phase 2Completed

Study of Silodosin to Facilitate Passage of Urinary Stones

Role: lead

NCT01140217Phase 3Completed

Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception

Role: lead

NCT01161563Phase 4Completed

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

Role: lead

NCT00223977Phase 2Completed

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

Role: lead

NCT00919113Phase 2Completed

Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome

Role: lead

NCT01553123Phase 3Withdrawn

Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

Role: lead

NCT01323140Phase 2Completed

Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems

Role: lead

NCT00224094Phase 4Completed

A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women

Role: lead

NCT00926926Phase 1Completed

Effects of Oxybutynin Topical Gel on Gastric Emptying

Role: lead

NCT01104246Phase 1Completed

Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men

Role: lead

NCT00354692Phase 4Completed

Effect of Two Iron Preparations on Protein in the Urine

Role: lead

NCT00223964Phase 4Completed

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

Role: lead

NCT00224055Phase 4Completed

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Role: lead

NCT00224042Phase 4Completed

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents

Role: lead